Spiriva Respimat (tiotropium) will be the first long-acting anticholinergic for ASTHMA

December 2015

Spiriva Respimat (tiotropium) will be the first long-acting anticholinergic for ASTHMA. It won't just be for COPD anymore.

But don't expect to use it first-line for asthma.

Adding Spiriva to a medium-dose inhaled steroid may improve lung function similar to adding a long-acting beta-agonist (salmeterol, etc).

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote